MeritValue

SELECTIS HEALTH, INC.

GBCSdata completeness 100%15 fiscal years on file

Data notes: no data for concept 'investmentsAtFairValue'; no data for concept 'netInvestmentIncome'; no data for concept 'gainsOnRealEstateSales'

The thesis, from the filings

SELECTIS HEALTH, INC. earns about -162% on equity, but has diluted owners by 11% over 5 years — worth asking whether the growth reaches owners. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.

i. The business — what you’d actually own
FigureFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$29.3M1$40.6M2$36.8M3$39.5M4$41.4M4
Net income−$2.25M5−$2.4M6−$3.97M7−$2.42M8−$1.02M8
Operating cash flow−$270,9309−$305,14810$536,66611−$1.82M12$1.88M12
Capital expenditure$519,57513$222,36114$29,80515$36,06316$443,61116
Free cash flow (derived)−$790,5059−$527,50910$506,86111−$1.86M12$1.44M12
Total debt$43.8M17$36.7M18$36.3M19$43.6M20$41.8M20
Cash & equivalents$3.94M21$1.42M22$1.48M23$680,33224$1.01M24
Diluted shares2.8M3.1M3.1M3.1M3.1M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
−$20.25
your share of equity
Profit it earned you last year
−$3.31
Free cash flow it threw off
$4.69
Debt you’d be carrying
$136.44

10 shares is a claim on −$20.25 of net worth that earned you −$3.31 and generated $4.69 of cash last year, against $136.44 of debt.

iii. Is this a good business?
Moat signal · return on equity
-162% avg · 5y
FY21 -73%FY22 -251%FY23 —FY24 —FY25 —

It earned an average -162% on equity over 5 years. Compare that to what it costs to fund the business.

seeing a moat in the numbers →
Management signal · capital allocation
+11% shares · 5y

Share count is up 11% over 5 years — owners have been diluted. Worth asking what they got for it. Total debt has held roughly steady.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.5.0
DCF · Growth Exit 10Y
not applicable
REIT — real-estate depreciation is an accounting charge on assets that generally appreciate, so it inflates free cash flow and depresses reported earnings and book value at the same time. Every model here reads one of those, and none is a fair base. FFO/AFFO is the applicable measure — see the FFO capitalisation model, which values REITs from it.
DCF · Growth Exit 5Y
not applicable
REIT — real-estate depreciation is an accounting charge on assets that generally appreciate, so it inflates free cash flow and depresses reported earnings and book value at the same time. Every model here reads one of those, and none is a fair base. FFO/AFFO is the applicable measure — see the FFO capitalisation model, which values REITs from it.
Earnings Power Value
not applicable
REIT — real-estate depreciation is an accounting charge on assets that generally appreciate, so it inflates free cash flow and depresses reported earnings and book value at the same time. Every model here reads one of those, and none is a fair base. FFO/AFFO is the applicable measure — see the FFO capitalisation model, which values REITs from it.
FFO · Capitalized
not applicable
normalized (3y-median) FFO non-positive — capitalisation undefined.
Graham Number
not applicable
REIT — real-estate depreciation is an accounting charge on assets that generally appreciate, so it inflates free cash flow and depresses reported earnings and book value at the same time. Every model here reads one of those, and none is a fair base. FFO/AFFO is the applicable measure — see the FFO capitalisation model, which values REITs from it.

Different models answer different questions — which to trust when →

Sources — the receipts
  1. 10-K · period ending 2021-12-31 · accession 0001493152-23-022985 (RevenueFromContractWithCustomerExcludingAssessedTax)
  2. 10-K/A · period ending 2022-12-31 · accession 0001493152-24-039543 (RevenueFromContractWithCustomerExcludingAssessedTax)
  3. 10-K · period ending 2023-12-31 · accession 0001641172-25-004859 (RevenueFromContractWithCustomerExcludingAssessedTax)
  4. 10-K · period ending 2024-12-31 · accession 0001493152-26-016827 (RevenueFromContractWithCustomerExcludingAssessedTax)
  5. 10-K · period ending 2021-12-31 · accession 0001493152-23-022985 (NetIncomeLoss)
  6. 10-K/A · period ending 2022-12-31 · accession 0001493152-24-039543 (NetIncomeLoss)
  7. 10-K · period ending 2023-12-31 · accession 0001641172-25-004859 (NetIncomeLoss)
  8. 10-K · period ending 2024-12-31 · accession 0001493152-26-016827 (NetIncomeLoss)
  9. 10-K · period ending 2021-12-31 · accession 0001493152-23-022985 (NetCashProvidedByUsedInOperatingActivities)
  10. 10-K/A · period ending 2022-12-31 · accession 0001493152-24-039543 (NetCashProvidedByUsedInOperatingActivities)
  11. 10-K · period ending 2023-12-31 · accession 0001641172-25-004859 (NetCashProvidedByUsedInOperatingActivities)
  12. 10-K · period ending 2024-12-31 · accession 0001493152-26-016827 (NetCashProvidedByUsedInOperatingActivities)
  13. 10-K · period ending 2021-12-31 · accession 0001493152-23-022985 (PaymentsToAcquirePropertyPlantAndEquipment)
  14. 10-K/A · period ending 2022-12-31 · accession 0001493152-24-039543 (PaymentsToAcquirePropertyPlantAndEquipment)
  15. 10-K · period ending 2023-12-31 · accession 0001641172-25-004859 (PaymentsToAcquirePropertyPlantAndEquipment)
  16. 10-K · period ending 2024-12-31 · accession 0001493152-26-016827 (PaymentsToAcquirePropertyPlantAndEquipment)
  17. 10-K · period ending 2021-12-31 · accession 0001493152-23-022985 (LongTermDebtNoncurrent)
  18. 10-K/A · period ending 2022-12-31 · accession 0001493152-24-039543 (LongTermDebtNoncurrent)
  19. 10-K · period ending 2023-12-31 · accession 0001641172-25-004859 (LongTermDebtNoncurrent)
  20. 10-K · period ending 2024-12-31 · accession 0001493152-26-016827 (LongTermDebtNoncurrent)
  21. 10-K · period ending 2021-12-31 · accession 0001493152-23-022985 (CashAndCashEquivalentsAtCarryingValue)
  22. 10-K/A · period ending 2022-12-31 · accession 0001493152-24-039543 (CashAndCashEquivalentsAtCarryingValue)
  23. 10-K · period ending 2023-12-31 · accession 0001641172-25-004859 (CashAndCashEquivalentsAtCarryingValue)
  24. 10-K · period ending 2024-12-31 · accession 0001493152-26-016827 (CashAndCashEquivalentsAtCarryingValue)